Raphael Koch

8PUBLICATIONS
58CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Optical technologyEpidemiological methodsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 26, 2025
Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study.

Niklas Wiesmann, Dominic Enders, Antje Westendorf

|Oct 26, 2024
Retrospective Evaluation of GEC-ESTRO Constraints for Definitive Radiochemotherapy with Brachytherapy and Correlation with Oncologic Outcome in Cervical Cancer: A Monocenter Study.

Tom Schönicke, Raphael Koch, Isabel Vogt

|May 25, 2024
Microvascular Density Analysis of Patients with Inactive Systemic Lupus Erythematosus-A Two-Year Follow-Up Optical Coherence Tomography Angiography Study.

Martin Dominik Leclaire, Eliane Luisa Esser, Sebastian Dierse

|Oct 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

Raphael Koch, Lianne Haveman, Ruth Ladenstein

|Nov 18, 2022
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.

Andrew F Berdel, Raphael Koch, Joachim Gerss

|Apr 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

Raphael Koch, Hans Gelderblom, Lianne Haveman

Pageof 2

Frequent Collaborators

2 joint publications

Thomas Kühne

2 joint publications

Frieder Schaumburg

2 joint publications

Jarmila Kruseova

2 joint publications

Hans Gelderblom